You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ovarian Function Suppression

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial (Ovarian Function Suppression + Aromatase Inhibitor, Adjuvant Chemotherapy + Ovarian Function Suppression)

Not yet recruiting
  • Breast Cancer
  • Ovarian Function Suppression + Aromatase Inhibitor
  • Adjuvant Chemotherapy + Ovarian Function Suppression
  • (no location specified)
May 19, 2023

Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian

Not yet recruiting
  • Hormone-receptor-positive Breast Cancer
  • +3 more
  • Aromatase inhibitor
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Apr 5, 2023

Breast Cancer, Estrogen Receptor Positive Tumor, HER2-negative Breast Cancer Trial in Seoul (Ovarian function suppression with

Not yet recruiting
  • Breast Cancer
  • +4 more
  • Ovarian function suppression with endocrine treatments
  • Seoul, Korea, Korea, Republic of
    Gangnam Severance Hospital
Dec 18, 2022

Breast Cancer Invasive Trial in Seoul (Leuplin or zoladex)

Recruiting
  • Breast Cancer Invasive
  • Leuplin or zoladex
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Oct 16, 2022

HR+/HER2- Advanced Breast Cancer, Targeted Therapy Trial in Beijing (Everolimus, Chidamide, Endocrine therapy)

Recruiting
  • HR+/HER2- Advanced Breast Cancer
  • Targeted Therapy
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Aug 1, 2023

Breast Cancer Trial in Shanghai (OFS + Anastrozole, OFS + Exemestane)

Completed
  • Breast Cancer
  • OFS + Anastrozole
  • OFS + Exemestane
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Mar 28, 2022

Breast Cancer Survivors, Sexual Function Disturbances, Ovarian Suppression Treatment Trial in Boston (Group Session, Telephone

Completed
  • Breast Cancer Survivors
  • +2 more
  • Group Session
  • Telephone Booster
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Nov 11, 2021

Metastatic Breast Cancer Trial in Johannesburg (Palbociclib, Exemestane, Goserelin)

Recruiting
  • Metastatic Breast Cancer
  • Johannesburg, South Africa
    Wits Oncology center
Jul 22, 2021

RWE About QOL and Compliance of Patients With OFS in China

Not yet recruiting
  • Breast Cancer
  • +2 more
  • 3M GnRHa
  • 1M GnRHa
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 15, 2021

Cognitive Impairment, Estrogen Deficiency, Menopause Trial in Aurora, Boulder (GnRHant + E2, GnRHant + Placebo)

Completed
  • Cognitive Impairment
  • +4 more
  • GnRHant + E2
  • GnRHant + Placebo
  • Aurora, Colorado
  • +1 more
Jun 3, 2021

the Correlation Between Ovarian Function and Serum Biomarkers

Recruiting
  • Premature Ovarian Insufficiency
  • +5 more
  • blood test
  • Beijing, China
    Dongzhimen Hospital, Beijing University of Chinese Medicine
Oct 25, 2023

Breast Cancer Trial in Guangzhou (Tucidinostat, Exemestane, Ovarian function suppression)

Unknown status
  • Breast Cancer
  • Guangzhou, Guangdong, China
    The first affiliated hospital of Sun Yat-Sen university
Jul 22, 2020

Improve Sexual Health, Improve Vulvovaginal Health Trial in United States (questionnaires, moisturizers)

Recruiting
  • Improve Sexual Health
  • Improve Vulvovaginal Health
  • questionnaires
  • moisturizers
  • Basking Ridge, New Jersey
  • +6 more
Jun 9, 2023

Premature Ventricular Contractions, Ventricular Dysfunction, Left Trial (Experimental group, Control group)

Not yet recruiting
  • Premature Ventricular Contractions
  • Ventricular Dysfunction, Left
  • Experimental group
  • Control group
  • (no location specified)
Mar 27, 2023

Systemic Lupus Erythematosus Trial (Etonogestrel)

Not yet recruiting
  • Systemic Lupus Erythematosus
  • (no location specified)
Mar 17, 2023

Poor Ovarian Response Trial in Beijing (Jiajian Guishen granules, coenzyme Q10)

Not yet recruiting
  • Poor Ovarian Response
  • Jiajian Guishen granules
  • coenzyme Q10
  • Beijing, Beijing, China
  • +1 more
Oct 18, 2023

Associated Factors on Cognition Function in Premature Ovarian

Recruiting
  • Premature Ovarian Failure
    • Shanghai, Shanghai, China
      The International Peace Maternity and Child Health Hospital
    Nov 10, 2023

    Decreased Ovarian Reserve Trial in Wuhan (acupuncture, Sham acupuncture)

    Recruiting
    • Decreased Ovarian Reserve
    • acupuncture
    • Sham acupuncture
    • Wuhan, Hubei, China
      Tongji Hospital,Tongji medical college,HUST
    Dec 1, 2022

    Ovarian Tumor Epithelial Trial (acute normovolemic hemodilution (ANH), acute hypervolemic hemodilution (AHH))

    Completed
    • Ovarian Neoplasm Epithelial
    • acute normovolemic hemodilution (ANH)
    • acute hypervolemic hemodilution (AHH)
    • (no location specified)
    Oct 21, 2023

    Ovarian Reserve Trial in Madrid (Danazol/Placebo, Without intervention)

    Completed
    • Ovarian Reserve
    • Danazol/Placebo
    • Without intervention
    • Madrid, Spain
      Ivirma Madrid
    Aug 9, 2022

    Contraception Trial in Salt Lake City (ENG implant, oral ulipristal acetate)

    Active, not recruiting
    • Contraception
    • ENG implant
    • oral ulipristal acetate
    • Salt Lake City, Utah
      University of Utah
    Nov 1, 2022

    Autoimmune Diseases, Premature Ovarian Insufficiency Trial in Stockholm (Rituximab)

    Recruiting
    • Autoimmune Diseases
    • Premature Ovarian Insufficiency
    • Stockholm, Sweden
      Angelica Hirshberg
    Oct 20, 2022

    Pregnancy Prevention Trial in Mahape (LSP-5415)

    Recruiting
    • Pregnancy Prevention
    • Mahape, Mumbai, India
      Site 01
    Jul 18, 2022

    Narcotrend and Cerebral Function Analysing Monitor in Intensive

    Recruiting
    • Traumatic Brain Injury
    • +8 more
    • Narcotrend compared to Cerebral Function Analysing Monitor (CFAM)
    • Nottingham, Nottinghamshire, United Kingdom
      Nottingham University Hospitals Trust
    Oct 2, 2023

    Estrogen Receptor Positive Breast Cancer, Progesterone Receptor Positive Tumor, Recurrent Breast Carcinoma Trial in Canada,

    Active, not recruiting
    Has Results
    • Estrogen Receptor Positive Breast Cancer
    • +7 more
    • Birmingham, Alabama
    • +499 more
    Nov 15, 2022